MOBIC 15 mg/1.5 ml, solution for injection 3 ampoules of 1.5 ml
Brand page: Mobic (meloxicam) — all forms and strengths in France
Active ingredients: MÉLOXICAM
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection3 ampoules of 1.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOBIC 15 mg/1,5 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 3 ampoule(s) en verre de 1,5 ml
- Marketing authorisation holder
- BOEHRINGER INGELHEIM FRANCE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60821012CIP73539745CIP133400935397454Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉLOXICAMsolution | 15 mg · une ampoule de 1,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.